CTLA4 and Miyoshi myopathy: Likewise, the CTLA-4 expression was also recently found to be lower and increasing with MM progression [39], an observation consistent with our finding of the significant increase in CTLA-4 fluorescence intensity on CD4 T cells (both Teff and Treg) to normal levels in patients with refractory disease.